Skip to content
Research Article Open access CC BY 4.0

Evaluation of Plasma Fibrinogen Level, Platelet Count & Lipid Profile as Predictors of Cardiovascular Disease among Bangladeshi Healthy Male Smokers

Tarak Nath Das, Sumi Dey, Israt Jahan Chowdhury, Jakir Mohammed Hossen, Rahatul Jannat Nishat, Rifat Chowdhury, Asfaq Rafed Rahman, Nisat Zabin

Asian Journal of Medicine and Health · pp. 182–193 · Published 26 Jun 2024

10.9734/ajmah/2024/v22i71059

Abstract

Background: Smoking represents a substantial global health challenge, correlating with heightened rates of mortality and morbidity, notably including the onset of cancer. Within tobacco smoke are carcinogenic substances capable of perturbing cellular mechanisms and immune responses, thereby potentially influencing coagulation metrics and lipid profiles. Objective: This study aimed to investigate the plasma fibrinogen level, platelet count & lipid profile as predictors of cardiovascular disease among Bangladeshi healthy male smokers. Methods: A cross-sectional analytical study was conducted at the Department of Physiology, Sir Salimullah Medical College (SSMC) in Dhaka, Bangladesh, from July 1, 2018, to June 30, 2019. Seventy male participants aged 20 to 40 years were enrolled, comprising 35 healthy non-smokers (Group A) and 35 male smokers (Group B). Smokers were further categorized into two groups based on pack year (5-15 pack year for B1 & >15 pack year for B2). Coagulation parameters including plasma fibrinogen and platelet count and lipid profile were assessed. Results: The study comprised 70 subjects, evenly divided into Group A and Group B, with comparable mean ages of 33.17 ± 2.91 years and 34.11 ± 3.18 years, respectively, and similar mean body mass index (BMI) values of 24.36 ± 2.28 kg/m2 and 24.68 ± 2.33 kg/m2. Plasma fibrinogen levels were significantly higher in Group B (315.55 ± 67.79 mg/dL) compared to Group A (222.49 ± 23.03 mg/dL), as were platelet counts (285.14 ± 34.33 x109/L in Group B vs. 235.20 ± 46.83 x109/L in Group A). Further stratification of Group B revealed higher fibrinogen levels in both subgroups, B1 and B2, compared to Group A, with B2 exhibiting the highest fibrinogen levels. Platelet counts followed a similar trend, with both B1 and B2 having significantly higher counts than Group A. Plasma fibrinogen level was positively correlated with pack-years of smoking, while platelet counts showed a positive but statistically non-significant correlation. Smokers exhibited elevated total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL) levels, along with decreased high-density lipoprotein (HDL) levels compared to non-smokers. Moreover, there was a significant positive correlation between pack-years of smoking and TC, TG, and LDL levels, while HDL levels exhibited a significant negative correlation. These findings underscore the complex interplay between smoking, coagulation parameters, and lipid profiles, emphasizing the multifaceted impact of smoking on cardiovascular health. Conclusion: In conclusion, the study highlights the intricate relationship between smoking, coagulation parameters, and lipid profiles in a cohort of 70 subjects. Smokers exhibited elevated plasma fibrinogen levels and platelet counts compared to non-smokers, with a significant positive correlation observed between pack-years of smoking and these coagulation parameters. Additionally, smokers demonstrated higher levels of total cholesterol, triglycerides, and low-density lipoprotein, alongside lower levels of high-density lipoprotein, indicative of dyslipidemic state in the direction of increased risk for coronary artery disease. Furthermore, the discovered alterations in plasma fibrinogen, platelet, and lipid profiles serve as early predictors of cardiovascular disease, advocating for proactive management strategies in individuals with a smoking history.

Smoking coagulation parameters plasma fibrinogen platelet count lipid profile

References (35)

  1. 1 Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction [DOI]
  2. 2 A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction [DOI]
  3. 3 Platelet Activation and Blood Coagulation [DOI]
  4. 4 Dysfunctional Endothelial Nitric Oxide Biosynthesis in Healthy Smokers With Impaired Endothelium-Dependent Vasodilatation [DOI]
  5. 5 Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction [DOI]
  6. 6 Coagulation and Bleeding Disorders: Review and Update [DOI]
  7. 7 A Systematic Review of the Effects of Smoking on the Cardiovascular System and General Health [DOI]
  8. 8 Relationship between Biomarkers of Cigarette Smoke Exposure and Biomarkers of Inflammation, Oxidative Stress, and Platelet Activation in Adult Cigarette Smokers [DOI]
  9. 9 Smoking, Other Risk Factors and Fibrinogen Levels Evidence of Effect Modification [DOI]
  10. 10 Effect of Smoking Cessation on Mean Platelet Volume [DOI]
  11. 11 Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States [DOI]
  12. 12 Effects of cigarette smoking on morphological features of platelets in healthy men [DOI]
  13. 13 Effects of smoking on healthy young men’s hematologic parameters [DOI]
  14. 14 The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: the Oslo Youth Study. [DOI]
  15. 15 Thrombopoietin contributes to enhanced platelet activation in cigarette smokers [DOI]
  16. 16 Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction [DOI]
  17. 17 Effects of smoking and abstention from smoking on fibrinogen synthesis in humans [DOI]
  18. 18 Evaluation of the impact of cigarette smoking on platelet parameters [DOI]
  19. 19 Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population [DOI]
  20. 20 Effect of Cigarette Smoking on Plasma Fibrinogen and Platelet Count [DOI]
  21. 21 Long-term smoking results in haemostatic dysfunction in chronic smokers [DOI]
  22. 22 Alterations in Blood Coagulation and Viscosity Among Young Male Cigarette Smokers of Al-Jouf Region in Saudi Arabia [DOI]
  23. 23 Dose—effect relationship between smoking and blood rheology [DOI]
  24. 24 Platelet reactivity, fibrinogen and smoking [DOI]
  25. 25 Association between cigarette smoking and coronary arterial disease in patients in India: how quantitative is it? An assessment by selective coronary arteriography [DOI]
  26. 26 EFFECTS OF CIGARETTE SMOKING ON SOME COAGULATION PARAMETERS OF SMOKERS IN NNEWI METROPOLIS [DOI]
  27. 27 Is fibrinogen a reliable haemostatic marker for monitoring possible risks of thromboembolic events in smokers
  28. 28 Alteration in Plasma Proteins and Platelet Functions with Aging and Cigarette Smoking in Healthy Men [DOI]
  29. 29 The relationship of white blood cell and platelet counts to cigarette smoking in adult Nigerians.
  30. 30 Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease [DOI]
  31. 31 The Effect of Smoking on Inflammation, Prothrombotic State and Endothelial Dysfunction in Patients with Essential Hypertension [DOI]
  32. 32 LIPID PROFILE, PLASMA FIBRINOGEN, AND PLATELET COUNT AS MARKERS OF CARDIO VASCULAR DISEASE IN SMOKERS DUE TO FREE RADICAL GENERATION [DOI]
  33. 33 Prevalence of Smoking among Patients Attending Cardiac Clinic in Gaza Strip [DOI]
  34. 34 A study of lipid profile in young smokers and non-smokers [DOI]
  35. 35 Augmented oxidative stress of platelets in chronic smokers : mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

65

Page views

0

PDF downloads

20

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.